Fig. 1From: Meeting patient expectations in migraine treatment: what are the key endpoints?Almotriptan in triptan-naive versus experienced patients (treated with almotriptan 12.5 mg) after Pascual et al. [14] with permission. 2-h PR pain relief at 2 h, 2-h PF pain-free at 2 h, 2-h SPF sustained pain-free at 2–24 h without rescue medication, SNAE sustained pain-free and no AEs, Recur headache recurrence at 24 h, Rescue rescue medication 2–24 h, AE adverse eventBack to article page